Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

被引：0
|
作者：
Vittayawacharin, Pongthep [1 ,2 ]
Jeyakumar, Deepa [1 ]
Lee, Benjamin J. [3 ]
Doh, Jean [3 ]
Griffin, Shawn [4 ]
Van Etten, Richard A. [1 ]
Kongtim, Piyanuch [1 ]
Ciurea, Stefan [1 ]
机构：
[1] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Hematopoiet Stem Cell Transplantat & Cellular The, Orange, CA USA
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Div Hematol,Dept Med, Bangkok, Thailand
[3] Univ Calif Irvine, Dept Pharm, Orange, CA USA
[4] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm Practice, Orange, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A pilot study of mycophenolate mofetil for the prophylaxis and treatment of graft-versus-host disease
    Luo, Chengwei
    Du, Xin
    Weng, Jianyu
    Guo, Rong
    Lu, Zesheng
    BLOOD, 2007, 110 (11) : 319B - 319B
  • [32] Response to mycophenolate mofetil therapy for refractory chronic graft-versus-host disease
    Busca, A
    Locatelli, F
    Marmont, F
    Audisio, E
    Falda, M
    HAEMATOLOGICA, 2003, 88 (07) : 837 - 838
  • [33] Randomized Trial of Tacrolimus and Methotrexate Versus Tacrolimus, Reduced Dose Methotrexate, and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease after Myeloablative Related and Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
    Hamilton, Betty K.
    Rybicki, Lisa A.
    Lucas, Taylor
    Corrigan, Donna
    Kalaycio, Matt
    Hanna, Rabi
    Rotz, Seth J.
    Dean, Robert M.
    Gerds, Aaron T.
    Hill, Brian T.
    Jagadeesh, Deepa
    Pohlman, Brad
    Copelan, Edward A.
    Majhail, Navneet S.
    BLOOD, 2021, 138
  • [34] Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease
    Martin, Paul J.
    Storer, Barry E.
    Rowley, Scott D.
    Flowers, Mary E. D.
    Lee, Stephanie J.
    Carpenter, Paul A.
    Wingard, John R.
    Shaughnessy, Paul J.
    DeVetten, Marcel P.
    Jagasia, Madan
    Fay, Joseph W.
    van Besien, Koen
    Gupta, Vikas
    Kitko, Carrie
    Johnston, Laura J.
    Maziarz, Richard T.
    Arora, Mukta
    Jacobson, Pamala A.
    Weisdorf, Daniel
    BLOOD, 2009, 113 (21) : 5074 - 5082
  • [35] POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGHER-RISK MYELODYSPLASTIC SYNDROME
    Choi, E. -J.
    Park, H. -S.
    Lee, J. -H.
    Lee, K. -H.
    Lee, J. -H.
    LEUKEMIA RESEARCH, 2021, 108 : S49 - S49
  • [36] Post-transplantation cyclophosphamide compared to graft-versus-host disease prophylaxis with ATG in mismatched unrelated donor hematopoietic stem cell transplantation
    Soltermann, Yves
    Heim, Dominik
    Baldomero, Helen
    Medinger, Michael
    Halter, Jorg P.
    Passweg, Jakob P.
    Kleber, Martina
    BONE MARROW TRANSPLANTATION, 2018, 53 : 75 - 76
  • [37] Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis
    Jullien, Maxime
    Orvain, Corentin
    Berceanu, Ana
    Couturier, Marie-Anne
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Klemencie, Marion
    Schmidt, Aline
    Hunault, Mathilde
    Daguindau, Etienne
    Roussel, Xavier
    Delepine, Pascal
    Guillerm, Gaelle
    Giltat, Aurelien
    Francois, Sylvie
    Thepot, Sylvain
    Le Gouill, Steven
    Bene, Marie-C
    Chevallier, Patrice
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 861.e1 - 861.e7
  • [38] Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Higher-Risk Myelodysplastic Syndrome
    Choi, Eun-Ji
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo Hyung
    Lee, Youngshin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Je-Hwan
    BLOOD, 2021, 138
  • [39] Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis-implications for post-transplantation bone disease
    Westenfeld, Ralf
    Schlieper, Georg
    Woeltje, Michael
    Gawlik, Alexander
    Brandenburg, Vincent
    Rutkowski, Przemyslaw
    Floege, Juergen
    Jahnen-Dechent, Willi
    Ketteler, Markus
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (12) : 4115 - 4123
  • [40] High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantation Patients
    Al-Kadhimi, Zaid
    Gul, Zartash
    Chen, Wei
    Smith, Daryn
    Abidi, Muneer
    Deol, Abhinav
    Ayash, Lois
    Lum, Lawrence
    Waller, Edmund K.
    Ratanatharathorn, Voravit
    Uberti, Joseph
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) : 979 - 985
12345